Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.

Switzerland

Loading...

CHF overview

PairLatest rateToday's change1 year change
CHFGBP0.9429
GBP
-0.0002 / -0.02%0.0331 / 3.64%
Today
0.8915May 29 20250.9713Mar 02 2026
CHFEUR1.09
EUR
-0.0018 / -0.17%0.0207 / 1.93%
Today
1.06Aug 18 20251.11Mar 09 2026
CHFUSD1.29
USD
0.0079 / 0.61%0.0687 / 5.65%
Today
1.18May 12 20251.31Jan 27 2026
CHFJPY200.26
JPY
-1.38 / -0.68%27.02 / 15.60%
Today
172.60May 20 2025204.42Apr 21 2026
CHFAUD1.77
AUD
-0.0089 / -0.50%-0.1035 / -5.53%
Today
1.76Apr 29 20261.97Oct 17 2025
CHFCAD1.75
CAD
0.0084 / 0.48%0.0718 / 4.28%
Today
1.65May 12 20251.79Jan 27 2026
CHFCNY8.75
CNY
0.028 / 0.32%-0.0272 / -0.31%
Today
8.49May 12 20259.14Jan 27 2026

Equity fund country flows

This chart shows the cumulative weekly equity in country flows into or out of Switzerland in USD. EPFR Global provides global coverage of foreign investor flows, tracking over 15,000 funds domiciled around the world.
As of May 19 2021.

Market movers

Constituents of the SMI with the highest percent gain over one day.
ListingLastChangeVolume
Huber+Suhner AGHUBN:SWX271.50
CHF
+40.50
+17.53%
58.74k
Lastminute.com NVLMN:SWX12.25
CHF
+1.00
+8.89%
31.77k
Compagnie Financiere Richemont SACFR:SWX158.05
CHF
+11.35
+7.74%
453.15k
Tecan Group AGTECN:SWX134.40
CHF
+9.40
+7.52%
41.14k
Komax Holding AGKOMN:SWX57.10
CHF
+3.60
+6.73%
7.99k
Sonova Holding AGSOON:SWX185.70
CHF
+11.30
+6.48%
132.53k
Sika AGSIKA:SWX149.80
CHF
+8.00
+5.64%
207.50k
Newron Pharmaceuticals SpANWRN:SWX13.86
CHF
+0.72
+5.48%
41.96k
Georg Fischer AGGF:SWX45.32
CHF
+2.24
+5.20%
114.82k
R&S Group Holding AGRSGN:SWX28.76
CHF
+1.42
+5.19%
113.79k
Data delayed at least 15 minutes, as of May 06 2026 12:31 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.